Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Self-Assessment Clinical Symptom Score (SCST)
研究概览
简要总结
Allergic rhinitis is a very common condition (affecting 1 in 5 people in Europe) and a costly one for society (direct and indirect costs). Symptoms vary depending on the time of year, and treatments are primarily symptomatic, with follow-up in ENT consultations. Scientific societies (EAACI, FDA, EMA) recommend using a universal tool (severity score) (the CSMS score, SCST in French) to monitor severity and follow-up, and to obtain consistent data that can be extrapolated to other scientific data (meta-analyses).
Therefore, investigators in the ENT department use this SCST score (as well as others such as the SNOT 22 score) to assess the severity of allergic rhinitis in our patients and its progression.
Tbe investigators wish to confirm the acceptability of this tool for patients, and the statistical value of its properties.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult (≥18 years)
- •Follow-up at the ENT department of Hautepierre University Hospital for allergic rhinitis
排除标准
- •Asymptomatic individuals not requiring follow-up consultations.
结局指标
主要结局
Self-Assessment Clinical Symptom Score (SCST)
时间窗: Up to 6 months
1. Rating Scale Each symptom is rated by the patient according to its intensity: * 0: absent * 1: mild * 2: moderate * 3: severe 2. Calculating the Score * Add the scores for each symptom. * The total SCST score reflects the overall severity of the symptoms: * Low score → mild symptoms * High score → severe symptoms 3. Interpretation * Before treatment: establish a baseline. * After treatment: compare the scores to assess effectiveness. * A decrease in the score indicates clinical improvement.
次要结局
未报告次要终点